Indofarma Tbk. vs Tigaraksa Satria Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Tigaraksa Satria Tbk. trades at Rp4,970 (market cap 4.56T, 300 24h volume). The key difference: Tigaraksa Satria Tbk. is far larger — about 11.7× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | TGKA | |
|---|---|---|
Market Cap | 390.51B | 4.56T |
Volume | — | 300 |
Lot | — | 3 |
Turnover | — | 1.5M |
Average Price | — | 5,015 |
Value | — | 1.5M |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT Tigaraksa Satria Tbk (the Company) was established in Jakarta based on notarial deed No. 35 of M.M.I. Wiardi, S.H., dated November 17, 1986. PT. Tigaraksa Satria is a distributor of Nutrition, Chemicals, Cosmetic, Books, Garments and other consumer goods. Founded in 1987 as a subsidiary of PT. Tigaraksa, the company handles the dosmetic distribution products for more than 20 pricipals.
Read more on TGKA →